Neil Thompson
Sales & Marketing at POLYPEPTIDE GROUP AG
Net worth: 41 539 $ as of 31/05/2024
Profile
Mr. Neil J.
Thompson is a Director-Global Sales & Marketing at PolyPeptide Group AG.
Mr. Thompson was previously employed as a Product Manager-Peptide by Bachem (U.K.) Ltd., a Product Manager by Bachem AG, and an Assistant Manager-Production by Peninsula Laboratories Europe Ltd.
He received his undergraduate degree from Liverpool John Moores University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
POLYPEPTIDE GROUP AG
0.00% | 31/12/2023 | 1,122 ( 0.00% ) | 41 539 $ | 31/05/2024 |
Neil Thompson active positions
| Companies | Position | Start |
|---|---|---|
| POLYPEPTIDE GROUP AG | Sales & Marketing | 01/01/2022 |
Former positions of Neil Thompson
| Companies | Position | End |
|---|---|---|
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Corporate Officer/Principal | 01/01/2003 |
Bachem (U.K.) Ltd.
 Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Corporate Officer/Principal | 01/01/2003 |
Training of Neil Thompson
| Liverpool John Moores University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| POLYPEPTIDE GROUP AG | Health Technology |
| Private companies | 2 |
|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Bachem (U.K.) Ltd.
Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Health Technology |
- Stock Market
- Insiders
- Neil Thompson
